Teva Pharmaceutical Industries Limited
TEVA
$15.38
-$0.07-0.45%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | 7.32% | -7.99% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 7.32% | -7.99% | |||
Cost of Revenue | 2.98% | -4.50% | |||
Gross Profit | 11.99% | -11.46% | |||
SG&A Expenses | 4.35% | -3.47% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | 150.00% | -92.86% | |||
Total Operating Expenses | 3.14% | -4.62% | |||
Operating Income | 26.09% | -20.60% | |||
Income Before Tax | -30.61% | 219.03% | |||
Income Tax Expenses | -205.41% | 164.29% | |||
Earnings from Continuing Operations | 28.18% | 180.00% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -110.34% | |||
Net Income | 31.78% | 198.62% | |||
EBIT | 26.09% | -20.60% | |||
EBITDA | 20.15% | -17.99% | |||
EPS Basic | 30.80% | 198.17% | |||
Normalized Basic EPS | 35.08% | -38.75% | |||
EPS Diluted | 33.33% | 193.99% | |||
Normalized Diluted EPS | 35.89% | -39.86% | |||
Average Basic Shares Outstanding | 0.79% | 0.44% | |||
Average Diluted Shares Outstanding | 0.17% | 2.29% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |